Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Now - Now ...
View:
Post by MrMugsy on Apr 20, 2022 9:35am

Now - Now ...

Let's not call me a liar just because you don't like the numbers.

You only have to go to Medison's website to find the numbers.  Don't take it personally.

: )

This is the other component that reminded me of the declining dividend payment from Medison - due to declining profitability.  A blast from the past if you will ...

https://www.globenewswire.com/news-release/2019/03/15/1754996/0/en/Knight-Addresses-Misleading-and-Self-Serving-Plan-Issued-by-Disgruntled-Director.html

So ... no point trying to paint Meir as some wise pharma player who was going to help us.  It was so obvious that he saw something he wanted, couldn't get to it, made a play to try and take it.

The numbers are Meir-ly saying ... he's not that capable.  That's all !!!

Funny that he's trying to make a play in Canada (not really going well - seems really slow - go figure) while we're looking to higher growth geographies for the future.
Comment by Chianchin on Apr 20, 2022 9:42am
I repeate again you or me do not know if Medison is making a profit or not. What we do know 100% is that GUD loses money every quarter and it has lost 25% share price value since Meir left GUD. Hence how could you call GUD a success story? Are you financially insane or masochist?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities